Home › NDC Lookup › Labelers › Genzyme Corporation

Genzyme Corporation NDCs and Package Codes

This page lists NDC package records associated with labeler code 58468 (Genzyme Corporation) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

40
Package NDCs
37
Products
37
Active listings
0
Discontinued
19
Ingredients
1
Therapeutic classes
10
Dosage forms
3
With NADAC pricing

Portfolio

By therapeutic class
THYROID FUNCTION DIAGNOSTIC AGENTS 1
Top ingredients
AGALSIDASE BETA 3
laronidase 3
SEVELAMER CARBONATE 3
IMIGLUCERASE 3
THYROTROPIN ALFA 2
olipudase alfa-rpcp 2
Anti-thymocyte Globulin (Rabbit) 2
ALGLUCOSIDASE ALFA 2
ALEMTUZUMAB 2
teriflunomide 2
By dosage form
INJECTION, POWDER, LYOPHILIZED, FO... 14
TABLET, FILM COATED 6
INJECTION, SOLUTION, CONCENTRATE 4
SOLUTION 4
POWDER, FOR SUSPENSION 2
INJECTION, POWDER, FOR SOLUTION 2
INJECTION, SOLUTION 2
CAPSULE 1

Browse records — 37 products

Drug / product Billing NDC NADAC / unit Status
AGALSIDASE BETA 5 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Genzyme · NDC 58468-5030-01 · 1 mL in 1 VIAL (58468-5030-1) 58468-5030-01 — On market View →
ALDURAZYME laronidase 2.9 mg/5mL INJECTION, SOLUTION, CONCENTRATE Genzyme · NDC 58468-0070-01 · J1931 · 5 mL in 1 VIAL, GLASS (58468-0070-1) 58468-0070-01 — On market View →
ALDURAZYME laronidase 2.9 mg/5mL INJECTION, SOLUTION, CONCENTRATE Genzyme · NDC 58468-0070-01 · J1931 · 5 mL in 1 VIAL, GLASS (58468-0070-1) 58468-0070-01 — On market View →
ALDURAZYME laronidase 2.9 mg/5mL INJECTION, SOLUTION, CONCENTRATE Genzyme · NDC 58468-0070-01 · J1931 · 5 mL in 1 VIAL, GLASS (58468-0070-1) 58468-0070-01 — On market View →
Alglucosidase alfa 5 mg/mL SOLUTION Genzyme · NDC 58468-5005-01 · 72500 mL in 1 BAG (58468-5005-1) 58468-5005-01 — On market View →
Aubagio teriflunomide 14 mg/1 TABLET, FILM COATED Genzyme · NDC 58468-0210-01 · 1 BLISTER PACK in 1 CARTON (58468-0210-1) / 5 TABLET, FILM COATED in 1 BLISTER PACK 58468-0210-01 — On market View →
Aubagio teriflunomide 7 mg/1 TABLET, FILM COATED Genzyme · NDC 58468-0211-02 · 1 BLISTER PACK in 1 CARTON (58468-0211-2) / 5 TABLET, FILM COATED in 1 BLISTER PACK 58468-0211-02 — On market View →
AVALGLUCOSIDASE ALFA 100 mg/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Genzyme · NDC 58468-5011-01 · 10 mL in 1 VIAL (58468-5011-1) 58468-5011-01 — On market View →
Avalglucosidase alfa 10 mg/mL SOLUTION Genzyme · NDC 58468-5006-01 · 72500 mL in 1 BAG (58468-5006-1) 58468-5006-01 — On market View →
Cablivi caplacizumab KIT Genzyme · NDC 58468-0225-01 · 1 KIT in 1 CARTON (58468-0225-1) * 1 mL in 1 VIAL, GLASS (58468-0227-1) * 1 mL in 1 SYRINGE, GLASS (58468-0229-1) 58468-0225-01 — On market View →
Campath ALEMTUZUMAB 30 mg/mL INJECTION Genzyme · NDC 58468-0357-01 · 1 VIAL, SINGLE-USE in 1 CARTON (58468-0357-1) / 1 mL in 1 VIAL, SINGLE-USE 58468-0357-01 — On market View →
CAPRELSA Vandetanib 100 mg/1 TABLET, FILM COATED Genzyme · NDC 58468-7820-03 · 1 BOTTLE, PLASTIC in 1 CARTON (58468-7820-3) / 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC 58468-7820-03 — On market View →
CAPRELSA Vandetanib 300 mg/1 TABLET, FILM COATED Genzyme · NDC 58468-7840-03 · 1 BOTTLE, PLASTIC in 1 CARTON (58468-7840-3) / 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC 58468-7840-03 — On market View →
Cerdelga eliglustat 84 mg/1 CAPSULE Genzyme · NDC 58468-0220-01 · 4 BLISTER PACK in 1 CARTON (58468-0220-1) / 14 CAPSULE in 1 BLISTER PACK 58468-0220-01 — On market View →
Cerezyme IMIGLUCERASE 40 U/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Genzyme · NDC 58468-4663-01 · J1786 · 1 VIAL, GLASS in 1 CARTON (58468-4663-1) / 10 mL in 1 VIAL, GLASS 58468-4663-01 — On market View →
Cerezyme IMIGLUCERASE 40 U/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Genzyme · NDC 58468-4663-01 · J1786 · 1 VIAL, GLASS in 1 CARTON (58468-4663-1) / 10 mL in 1 VIAL, GLASS 58468-4663-01 — On market View →
Dupilumab 175 mg/mL SOLUTION Genzyme · NDC 58468-5151-01 · 3300 mL in 1 BOTTLE, PLASTIC (58468-5151-1) 58468-5151-01 — On market View →
Dupilumab 150 mg/mL SOLUTION Genzyme · NDC 58468-5150-01 · 3300 mL in 1 BOTTLE, PLASTIC (58468-5150-1) 58468-5150-01 — On market View →
Fabrazyme AGALSIDASE BETA 5 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Genzyme · NDC 58468-0040-01 · J0180 · 1 VIAL, GLASS in 1 CARTON (58468-0040-1) / 7 mL in 1 VIAL, GLASS 58468-0040-01 — On market View →
Fabrazyme AGALSIDASE BETA 5 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Genzyme · NDC 58468-0041-01 · J0180 · 1 VIAL, GLASS in 1 CARTON (58468-0041-1) / 1 mL in 1 VIAL, GLASS 58468-0041-01 — On market View →
IMIGLUCERASE 40 U/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Genzyme · NDC 58468-5010-01 · 10 mL in 1 VIAL (58468-5010-1) 58468-5010-01 — On market View →
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN 25 mg/5mL INJECTION, POWDER, FOR SOLUTION Genzyme · NDC 58468-5025-01 · 100000 mL in 1 BAG (58468-5025-1) 58468-5025-01 — On market View →
LEMTRADA ALEMTUZUMAB 12 mg/1.2mL INJECTION, SOLUTION, CONCENTRATE Genzyme · NDC 58468-0200-01 · J0202 · 1 VIAL, SINGLE-USE in 1 CARTON (58468-0200-1) / 1.2 mL in 1 VIAL, SINGLE-USE 58468-0200-01 — On market View →
Lumizyme ALGLUCOSIDASE ALFA 5 mg/mL INJECTION, POWDER, FOR SOLUTION Genzyme · NDC 58468-0160-01 · J0221 · 1 VIAL, SINGLE-USE in 1 CARTON (58468-0160-1) / 10.5 mL in 1 VIAL, SINGLE-USE 58468-0160-01 — On market View →
Nexviazyme avalglucosidase alfa-ngpt 100 mg/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Genzyme · NDC 58468-0426-01 · J0219 · 1 VIAL, SINGLE-DOSE in 1 CARTON (58468-0426-1) / 10 mL in 1 VIAL, SINGLE-DOSE 58468-0426-01 — On market View →
Qfitlia fitusiran 20 mg/.2mL INJECTION, SOLUTION Genzyme · NDC 58468-0347-01 · J7174 · 1 VIAL in 1 CARTON (58468-0347-1) / .2 mL in 1 VIAL 58468-0347-01 — On market View →
Qfitlia fitusiran 50 mg/.5mL INJECTION, SOLUTION Genzyme · NDC 58468-0348-01 · J7174 · 1 SYRINGE in 1 CARTON (58468-0348-1) / .5 mL in 1 SYRINGE 58468-0348-01 — On market View →
Renvela SEVELAMER CARBONATE 800 mg/1 POWDER, FOR SUSPENSION Genzyme · NDC 58468-0132-02 · 90 PACKET in 1 CARTON (58468-0132-2) / 1 POWDER, FOR SUSPENSION in 1 PACKET (58468-0132-1) 58468-0132-02 $17.156 /unit · NADAC On market View →
Renvela SEVELAMER CARBONATE 800 mg/1 TABLET, FILM COATED Genzyme · NDC 58468-0133-01 · 270 TABLET, FILM COATED in 1 BOTTLE (58468-0133-1) 58468-0133-01 $5.685 /unit · NADAC On market View →
Renvela SEVELAMER CARBONATE 2400 mg/1 POWDER, FOR SUSPENSION Genzyme · NDC 58468-0131-02 · 90 PACKET in 1 CARTON (58468-0131-2) / 1 POWDER, FOR SUSPENSION in 1 PACKET (58468-0131-1) 58468-0131-02 $17.193 /unit · NADAC On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.